Secondary-type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1.

Martha F WrightOlga PozdnyakovaRobert P HasserjianNidhi AggarwalAaron C ShaverOlga K WeinbergRebecca IrlmeierTatsuki KoyamaAdam C SeegmillerStephen A Strickland Emily F Mason

Published in: American journal of hematology (2022)

Keyphrases

acute myeloid leukemia
liver failure
allogeneic hematopoietic stem cell transplantation
respiratory failure
drug induced
bone marrow
hepatitis b virus
wild type
extracorporeal membrane oxygenation
acute lymphoblastic leukemia